These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20687240)

  • 1. Proceedings of the 10th International Conference on Alzheimer's Drug Discovery. September 14-15, 2009. Jersey City, New Jersey, USA.
    Curr Alzheimer Res; 2010 May; 7(3):188-279. PubMed ID: 20687240
    [No Abstract]   [Full Text] [Related]  

  • 2. The 14th International Conference on Alzheimer's Drug Discovery, 9 - 10 September 2013, in Jersey City, New Jersey.
    Glicksman MA
    Expert Opin Drug Discov; 2014 Feb; 9(2):215-20. PubMed ID: 24444088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease drug discovery: Abeta and beyond.
    Shineman DW; Fillit HM
    Curr Alzheimer Res; 2010 May; 7(3):188-9. PubMed ID: 20406195
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's Disease Drug Discovery--11th International Conference--Targeting Pathological Tau. 27-28 September 2010, Jersey City, NJ, USA.
    Wolfe MS
    IDrugs; 2010 Dec; 13(12):828-9. PubMed ID: 21154135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease Drug Discovery--11th International Conference--Promising New Therapeutic Approaches. 27-28 September 2010, Jersey City, NJ, USA.
    Wolfe MS
    IDrugs; 2010 Dec; 13(12):825-7. PubMed ID: 21154134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to the treatment of Alzheimer's disease.
    Rampa A; Bisi A
    Curr Top Med Chem; 2013; 13(15):1743-4. PubMed ID: 23931444
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.
    Goyal D; Shuaib S; Mann S; Goyal B
    ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the 8th International Conference on Alzheimer's Disease Drug Discovery.October 15-16, 2007. New York City, New York, USA.
    BMC Neurosci; 2008; 9 Suppl 2():S1-16. PubMed ID: 19241499
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward an integrated discovery and development program in Alzheimer's disease: the amyloid hypothesis.
    Greenberg BD; Murphy MF
    Neurobiol Aging; 1994; 15 Suppl 2():S105-9. PubMed ID: 7700430
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease.
    Geng J; Li M; Ren J; Wang E; Qu X
    Angew Chem Int Ed Engl; 2011 Apr; 50(18):4184-8. PubMed ID: 21433228
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug discovery for Alzheimer's disease: filling the pipeline.
    Horton AR; Fillit HM
    Curr Alzheimer Res; 2007 Dec; 4(5):501-2. PubMed ID: 18220510
    [No Abstract]   [Full Text] [Related]  

  • 13. Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.
    Ising C; Stanley M; Holtzman DM
    Clin Pharmacol Ther; 2015 Nov; 98(5):469-71. PubMed ID: 26250900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicine. Old drug, new hope for Alzheimer's disease.
    Strittmatter WJ
    Science; 2012 Mar; 335(6075):1447-8. PubMed ID: 22442467
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody drugs for Alzheimer's show glimmers of promise.
    Reardon S
    Nature; 2015 Jul; 523(7562):509-10. PubMed ID: 26223602
    [No Abstract]   [Full Text] [Related]  

  • 16. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
    Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
    Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection.
    Gozes I
    J Mol Neurosci; 2004; 24(3):333-6. PubMed ID: 15655257
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging amyloid disease-modifying drugs for Alzheimer's disease.
    Galimberti D; Scarpini E
    Expert Opin Emerg Drugs; 2016; 21(1):5-7. PubMed ID: 26817686
    [No Abstract]   [Full Text] [Related]  

  • 19. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
    Saxena U
    Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitarget drug design strategy in Alzheimer's disease: focus on cholinergic transmission and amyloid-β aggregation.
    Simoni E; Bartolini M; Abu IF; Blockley A; Gotti C; Bottegoni G; Caporaso R; Bergamini C; Andrisano V; Cavalli A; Mellor IR; Minarini A; Rosini M
    Future Med Chem; 2017 Jun; 9(10):953-963. PubMed ID: 28632446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.